Synopsis
A simplified version of the B1+ correction method using an approximation model was proposed for estimation of pharmacokinetic modeling parameters. The proposed method was evaluated in both simulation and in vivo DCE-MRI data, and was applied to DCE-MRI with 63 suspicious lesions from two MRI systems to investigate B1+ induced errors in Ktrans. Significant difference of estimated Ktrans distributions was observed between two systems, showing it's necessary to perform B1+ correction for DCE-MRI analysis between systems. Purpose
Quantitative dynamic
contrast-enhanced MRI (DCE-MRI) has shown great promise for detection and grading
of prostate cancer. Pharmacokinetic (PK) analysis is a powerful tool that provides
quantitative assessment for contrast uptake in DCE-MRI, however, B
1+
inhomogeneity,
leading to flip angle (FA) variation, can introduce considerable errors
into quantification, especially at 3.0T
1. It is shown that B
1+
variation in the prostate is around 10-15% at 3.0T
2, and several studies showed the influence of B
1+
inhomogeneity on PK parameters, such as K
trans, v
e and
k
ep 1. However, the conventional B
1+ correction
approach typically includes complex mathematical calculation and modeling,
limiting its practical application. In
this work, we present a simplified and practical approach that corrects B
1+
errors in quantitative DCE-MRI. We investigate
the error propagation from FA variation to the PK analysis using numerical
simulation and evaluate the correction of B
1+-induced PK
estimation errors in a total of 63 suspicious lesions of prostate cancer across
two different MRI systems.
Methods
As demonstrated in Fig. 1,
conventional B1+ correction requires a series of
quantification steps with updated parameters based on FA variation. This B1+
correction approach can be non-trivial particularly when the entire
PK modeling processing is not fully accessible (e.g, using a commercialized CAD
software), limiting the practical application of B1+ correction for
various DCE-MRI analysis.
In standard Tofts modeling3 with a population-averaged arterial input function (AIF)4, the B1+
correction can be simplified using Taylor series approximations under certain
conditions: 1) small FA, 2) small TR/T10 ,and 3) k ≈ 1, where T10 is pre-contrast T1 and k reflects B1 inhomogeneity calculated by FA'/FA. Provided these conditions are satisfied, we can express the B1+
correction process as 1) Ktrans'/Ktrans ≈ k2, 2) ve'/ve ≈ k2,
and 3) kep'/kep ≈ 1, where FA, Ktrans,
ve and kep are original values and
FA’, Ktrans’, ve’ and kep’ are B1+ corrected
values. Note that the proposed model now becomes independent of T10,
Ktrans, ve, and kep, enabling the direct B1+ correction of PK parameters without re-initiating pixel-by-pixel PK analysis.
We first
evaluated the proposed correction model by measuring differences between
conventional and proposed B1+ correction using
numerical simulation. The simulation was performed with 100 k values (0.7-1.3) for
27 combinations of representative Ktrans, ve and T10
values (Ktrans=0.5, 1.2, 2.5 min-1, ve=0.3,
0.5, 0.7 and T10=1500, 2000, 2500ms)5. Imaging Parameters are assumed following clinical protocols (FAVFA = 2°, 5°, 10°, 15°, FADCE = 12°, TR = 4ms).
With IRB
approval, the proposed correction model was retrospectively applied to 63 suspicious lesions
from 43 clinically-indicated prostate MRI exams to investigate the B1+ influence in Ktrans
across two 3.0T MRI scanners (Skyra and Trio, Siemens). A sub-cohort of
nine cases were also used for further evaluation of the proposed correction model.
B1+ maps were
measured using reference region variable flip angle (RR-VFA) method6,7, and regions of interest (ROIs) were manually drawn
on both prostate and suspicious lesions according to radiology reports (Fig. 2). RF transmission modes differed between two
scanners: Skyra was operated with “TrueForm” RF transmission (n=51) and Trio
was operated with circular polarization (n=12)8. T-tests were performed to evaluate the difference.
Results and Discussion
The
simulation results (Fig. 3) show that conventional and proposed methods are close to
identical, indicating that the difference between the two procedures
is minimal. Within a range of k between 0.7-1.3, the maximum relative error was 0.61% for Ktrans'/Ktrans and
0.64% for ve'/ve, negligible compared to error introduced
by B1+ inhomogeneity. With
nine DCE-MRI cases, the in-vivo results also confirm the approximation error of the proposed model is
negligible (0.87±0.08 % in the prostate and 0.95±0.07 % in suspicious lesions), as shown in Fig 2F.
The B1+, T10 and ΔKtrans
(defined as original Ktrans - corrected Ktrans) in
suspicious lesions were compared between two MRI scanners (Fig. 4). Due to the
different B1+ inhomogeneity patterns, both T10 and
ΔKtrans show different distributions across two MRI scanners. T10 inconsistency between two systems is
effectively reduced after the B1+ correction (puncorrected =2.88×10-6,
pcorrected=0.81). B1+-induced Ktrans
errors are also distinctively different (p = 2.21×10-4) between two systems, which could be a critical problem when comparing parameters between systems and suggests that B1+ correction is essential for quantitative
DCE-MRI analysis.
Conclusion
A
simple approximation method is proposed to provide practical solutions for B
1+
correction in quantitative DCE-MRI. The proposed model was evaluated by simulation and in-vivo data, and the approximation-induced error was shown
to be negligible relative to the conventional method. Inconsistent B
1+-induced K
trans error distributions between systems were observed, indicating the necessity of B
1+ correction for PK analysis.
Acknowledgements
Research reported in this abstract is supported by Siemens Medical Solutions.References
[1] Azlan, Che A., et al. B1 transmission-field
inhomogeneity and enhancement ratio errors in dynamic contrast-enhanced
MRI (DCE-MRI) of the breast at 3T. Journal of Magnetic
Resonance Imaging 31.1 (2010): 234-239.
[2] Zhong, Xinran, et al, Clinical Assessment of B1+
Inhomogeneity Effects on Quantitative Prostate MRI at 3.0 T, ISMRM, 2015 #1159
[3] Tofts, Paul S., et al. Estimating kinetic parameters from dynamic contrast-enhanced T 1-weighted
MRI of a diffusible tracer: standardized quantities and symbols. Journal
of Magnetic Resonance Imaging 10.3 (1999): 223-232.
[4] Parker, Geoff JM, et al. Experimentally-derived functional form for a population-averaged
high-temporal-resolution arterial input function for dynamic
contrast-enhanced MRI. Magnetic Resonance in Medicine 56.5
(2006): 993-1000.
[5] Hayes, Carmel, Anwar R.
Padhani, and Martin O. Leach. Assessing changes in tumor vascular
function using dynamic contrast-enhanced magnetic resonance imaging. NMR
in Biomedicine 15.2 (2002): 154-163.
[6] Sung, Kyunghyun, et al. Simultaneous T1 and B1+ Mapping Using Reference Region Variable Flip Angle Imaging. Magnetic Resonance in Medicine 70.4 (2013): 954-961
[7] Rangwala, Novena, et al. Validation of Variable Flip Angle Imaging-Based Simultaneous B1+ and T1 Mapping in the Prostate at 3T, ISMRM, 2015, #0492
[8] Blasche M, Riffel P, Matthias L. TimTX TrueShape and syngo ZOOMit Technical and Practical Aspects. MAGNETOM Flash 2012:74–84.